News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innovus Pharma Initiates Primate Safety Studies of Its Products That Affect Premature Ejaculation and Penile Sensation


7/3/2013 8:06:37 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LA JOLLA, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced it started two studies in non-human primates to evaluate the safety of daily use of EjectDelay and CIRCUMserum.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES